Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

Diabetologia

Volumn 36, Issue 11, 1993, Pages 1175-1184

  Uusitupa, M I J ^a   Niskanen, L K ^a   Siitonen, O ^a   Voutilainen, E ^a   Pyorala K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

albuminuria; Cardiovascular disease; diabetes mellitus; insulin; lipoprotein abnormalities; mortality; risk factors

Indexed keywords

INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEINURIA;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHOLESTEROL; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERTENSION; INCIDENCE; INSULIN; LIPOPROTEINS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PREVALENCE; RISK FACTORS; SMOKING; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0027360243     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00401063     Document Type: Article

References (56)

1. Diabetes and cardiovascular disease. The Framingham study
2. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study
3. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study
4. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women
5. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
6. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin dependent diabetes mellitus
7. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without nephropathy: incidence and risk factors
8. Diabetes and atherosclerosis: an epidemiologic view
9. The Whitehall Study: comparative mortality rates and indices of risk in diabetes
10. Glycation products and the pathogenesis of diabetic complications
11. Apolipoprotein B levels and altered lipoprotein composition in diabetes
12. Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes
13. Lipoprotein metabolism in diabetes mellitus
14. The role of insulin in atherosclerosis in diabetics and non-diabetics
15. Banting Lecture 1988: Role of insulin resistance in human disease
16. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects
17. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes
18. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL cholesterol and triglyceride levels
19. Diagnostic criteria used for the definition of diabetes in the district of University Central Hospital of Kuopio (Finnish)
20. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
21. Comparison of different analytical and precipitation methods for the direct estimation of serum high-density lipoprotein cholesterol
22. Enzymatische Bestimmung des Gesamtcholesterins im Serum
23. Triglycerides. Determination after enzymatic hydrolysis
24. Proteinuria in newly diagnosed type II diabetic patients
25. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (noninsulin-dependent) diabetic patients
26. A five year follow-up study on plasma insulin levels in newly diagnosed non-insulin-dependent diabetic patients and non-diabetic subjects
27. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects
28. The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO Multinational study
29. High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes
30. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes
31. Hyperinsulinemia is not a major coronary risk factor in elderly men
32. Integrated regulation of very low density lipoproteins, triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus
33. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease
34. Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease
35. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
36. Metabolism of lowdensity lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts
37. Relative atherogeneticity of different plasma lipoproteins
38. Low-density lipoprotein subclass patterns and risk of myocardial infarction
39. Receptor-mediated catabolism of low density lipoprotein in man: quantitation using glucosylated low density lipoprotein
40. High-density lipoprotein — the clinical implications of recent studies
41. Effect of insulin on the proliferation of cultural primate arterial smooth muscle cells
42. Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I
43. Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables
44. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients
45. Metabolic control and macrovascular disease
46. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
47. Microalbuminuria predicts mortality in non-insulin-dependent diabetes
48. Prospective study of microalbuminuria as predictor of mortality in NIDDM
49. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
50. Albuminuria reflects widespread vascular damage. The Steno hypothesis
51. Long-term effects of modest weight loss in type II diabetic patients
52. Maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes
53. Hyperlipidemia in diabetes mellitus